Login / Signup

Obstetric and neonatal outcomes following taxane use during pregnancy: a systematic review.

Alejandro Aranda-GutierrezAna S Ferrigno GuajardoBryan F Vaca-CartagenaDavid G Gonzalez-SanchezArantxa Ramirez-CisnerosAndrea Becerril-GaitanHatem A AzimCynthia Villarreal-Garza
Published in: BMC cancer (2024)
Taxanes appear to be safe following the first trimester of pregnancy, with obstetric and fetal outcomes being similar to those observed in the general obstetric population. Future studies should aim to determine the most effective taxane regimen and dosage for use during gestation, with a specific focus on treatment safety.
Keyphrases
  • pregnant women
  • metastatic breast cancer
  • preterm birth
  • current status
  • type diabetes
  • adipose tissue